173 related articles for article (PubMed ID: 22430635)
1. Expression of CD200 on AML blasts directly suppresses memory T-cell function.
Coles SJ; Hills RK; Wang EC; Burnett AK; Man S; Darley RL; Tonks A
Leukemia; 2012 Sep; 26(9):2148-51. PubMed ID: 22430635
[No Abstract] [Full Text] [Related]
2. Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts.
Gertner-Dardenne J; Castellano R; Mamessier E; Garbit S; Kochbati E; Etienne A; Charbonnier A; Collette Y; Vey N; Olive D
J Immunol; 2012 May; 188(9):4701-8. PubMed ID: 22467661
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts.
Le Dieu R; Taussig DC; Ramsay AG; Mitter R; Miraki-Moud F; Fatah R; Lee AM; Lister TA; Gribben JG
Blood; 2009 Oct; 114(18):3909-16. PubMed ID: 19710498
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic evolution of blast populations in pediatric acute myeloid leukemia.
Pereira WO; Correia RP; Hamerschlak N; Bacal NS; Campregher PV
Einstein (Sao Paulo); 2016 Mar; 14(2):288-9. PubMed ID: 26958979
[No Abstract] [Full Text] [Related]
5. Down-regulation of signal transducer and activator of transcription 3 improves human acute myeloid leukemia-derived dendritic cell function.
Brady MT; Miller A; Sait SN; Ford LA; Minderman H; Wang ES; Lee KP; Baumann H; Wetzler M
Leuk Res; 2013 Jul; 37(7):822-8. PubMed ID: 23628554
[TBL] [Abstract][Full Text] [Related]
6. A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia.
Yang T; Chen ZZ; Kolb HJ; Buhmann R
Immunobiology; 2013 Apr; 218(4):548-53. PubMed ID: 22883564
[TBL] [Abstract][Full Text] [Related]
7. The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse.
Coles SJ; Gilmour MN; Reid R; Knapper S; Burnett AK; Man S; Tonks A; Darley RL
Leukemia; 2015 Sep; 29(9):1952-4. PubMed ID: 25748687
[No Abstract] [Full Text] [Related]
8. Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cells.
van Luijn MM; van den Ancker W; Chamuleau ME; Zevenbergen A; Westers TM; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
Cancer Res; 2011 Apr; 71(7):2507-17. PubMed ID: 21310823
[TBL] [Abstract][Full Text] [Related]
9. Effects of interleukin-4 and interleukin-6 on the proliferation of CD34+ and CD34- blasts from acute myelogenous leukemia.
Akashi K; Harada M; Shibuya T; Eto T; Takamatsu Y; Teshima T; Niho Y
Blood; 1991 Jul; 78(1):197-204. PubMed ID: 1712640
[TBL] [Abstract][Full Text] [Related]
10. Improved effector function of leukemia-specific T-lymphocyte clones trained with AML-derived dendritic cells.
Schuster FR; Buhmann R; Reuther S; Hubner B; Grabrucker C; Liepert A; Reibke R; Lichtner P; Yang T; Kroell T; Kolb HJ; Borkhardt A; Schmetzer H
Cancer Genomics Proteomics; 2008; 5(5):275-86. PubMed ID: 19129558
[TBL] [Abstract][Full Text] [Related]
11. CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia.
Coles SJ; Wang EC; Man S; Hills RK; Burnett AK; Tonks A; Darley RL
Leukemia; 2011 May; 25(5):792-9. PubMed ID: 21274000
[TBL] [Abstract][Full Text] [Related]
12. Acute leukemia with t(8;21) can express T-lineage-associated markers.
Orazi A; Kotylo P; Neiman RS
Blood; 1992 Oct; 80(7):1855-6. PubMed ID: 1285763
[No Abstract] [Full Text] [Related]
13. Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia.
Weidmann E; Brieger J; Jahn B; Hoelzer D; Bergmann L; Mitrou PS
Ann Hematol; 1995 Mar; 70(3):153-8. PubMed ID: 7718644
[TBL] [Abstract][Full Text] [Related]
14. Dual attack on myeloblastic leukemic cells: the stimulus by B7 molecules matters.
Schmitt A; Schmitt M
Leuk Lymphoma; 2009 Mar; 50(3):315-6. PubMed ID: 19347721
[No Abstract] [Full Text] [Related]
15. Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia.
Zahran AM; Mohammed Saleh MF; Sayed MM; Rayan A; Ali AM; Hetta HF
Cancer Biomark; 2018; 22(3):587-595. PubMed ID: 29843224
[TBL] [Abstract][Full Text] [Related]
16. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
17. Leukemia blast-induced T-cell anergy demonstrated by leukemia-derived dendritic cells in acute myelogenous leukemia.
Narita M; Takahashi M; Liu A; Nikkuni K; Furukawa T; Toba K; Koyama S; Takai K; Sanada M; Aizawa Y
Exp Hematol; 2001 Jun; 29(6):709-19. PubMed ID: 11378266
[TBL] [Abstract][Full Text] [Related]
18. In vitro induction of a dendritic cell phenotype in primary human acute myelogenous leukemia (AML) blasts alters the chemokine release profile and increases the levels of T cell chemotactic CCL17 and CCL22.
Olsnes AM; Ryningen A; Ersvaer E; Bruserud Ø
J Interferon Cytokine Res; 2008 May; 28(5):297-310. PubMed ID: 18547160
[TBL] [Abstract][Full Text] [Related]
19. A novel self-lipid antigen targets human T cells against CD1c(+) leukemias.
Lepore M; de Lalla C; Gundimeda SR; Gsellinger H; Consonni M; Garavaglia C; Sansano S; Piccolo F; Scelfo A; Häussinger D; Montagna D; Locatelli F; Bonini C; Bondanza A; Forcina A; Li Z; Ni G; Ciceri F; Jenö P; Xia C; Mori L; Dellabona P; Casorati G; De Libero G
J Exp Med; 2014 Jun; 211(7):1363-77. PubMed ID: 24935257
[TBL] [Abstract][Full Text] [Related]
20. CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia.
Kenderian SS; Ruella M; Shestova O; Klichinsky M; Aikawa V; Morrissette JJ; Scholler J; Song D; Porter DL; Carroll M; June CH; Gill S
Leukemia; 2015 Aug; 29(8):1637-47. PubMed ID: 25721896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]